- Home
- TVA vs EHAB Comparison
TVA vs EHAB Comparison
Compare TVA & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVA
- EHAB
- Stock Information
- Founded
- TVA 2024
- EHAB 2014
- Country
- TVA United States
- EHAB United States
- Employees
- TVA N/A
- EHAB N/A
- Industry
- TVA
- EHAB Hospital/Nursing Management
- Sector
- TVA
- EHAB Health Care
- Exchange
- TVA Nasdaq
- EHAB Nasdaq
- Market Cap
- TVA 303.4M
- EHAB 330.2M
- IPO Year
- TVA 2025
- EHAB N/A
- Fundamental
- Price
- TVA $10.12
- EHAB $7.55
- Analyst Decision
- TVA
- EHAB Buy
- Analyst Count
- TVA 0
- EHAB 3
- Target Price
- TVA N/A
- EHAB $8.67
- AVG Volume (30 Days)
- TVA 123.0
- EHAB 609.9K
- Earning Date
- TVA 01-01-0001
- EHAB 08-06-2025
- Dividend Yield
- TVA N/A
- EHAB N/A
- EPS Growth
- TVA N/A
- EHAB N/A
- EPS
- TVA N/A
- EHAB N/A
- Revenue
- TVA N/A
- EHAB $1,037,800,000.00
- Revenue This Year
- TVA N/A
- EHAB $4.66
- Revenue Next Year
- TVA N/A
- EHAB $4.99
- P/E Ratio
- TVA N/A
- EHAB N/A
- Revenue Growth
- TVA N/A
- EHAB N/A
- 52 Week Low
- TVA $9.99
- EHAB $6.47
- 52 Week High
- TVA $10.34
- EHAB $10.91
- Technical
- Relative Strength Index (RSI)
- TVA N/A
- EHAB 53.74
- Support Level
- TVA N/A
- EHAB $7.32
- Resistance Level
- TVA N/A
- EHAB $7.78
- Average True Range (ATR)
- TVA 0.00
- EHAB 0.31
- MACD
- TVA 0.00
- EHAB 0.16
- Stochastic Oscillator
- TVA 0.00
- EHAB 72.14
About TVA Texas Ventures Acquisition III Corp Class A Ordinary Share
Texas Ventures Acquisition III Corp is a blank check company.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.